A sinister black finding in the stomach

Lancet. 2019 Mar 16;393(10176):1149. doi: 10.1016/S0140-6736(19)30423-4. Epub 2019 Mar 14.

Authors

Wladyslaw Januszewicz¹, Pippa Corrie², Hongxiang Liu³, James Chan³, Rebecca C Fitzgerald⁴, Massimiliano di Pietro⁵

Affiliations

¹ MRC Cancer Unit, University of Cambridge, Cambridge, UK; Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Centre for Postgraduate Education, Warsaw, Poland.
² Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Medical School, Cambridge, UK.
³ Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Medical School, Cambridge, UK.
⁴ MRC Cancer Unit, University of Cambridge, Cambridge, UK.
⁵ MRC Cancer Unit, University of Cambridge, Cambridge, UK. Electronic address: [email protected].

PMID: 30894270
DOI: 10.1016/S0140-6736(19)30423-4

No abstract available

Publication types

Case Reports

MeSH terms

Acrylonitrile / analogs & derivatives
Acrylonitrile / therapeutic use
Aged
Aniline Compounds / therapeutic use
Barrett Esophagus / diagnostic imaging*
Barrett Esophagus / pathology
Benzimidazoles / administration & dosage
Benzimidazoles / therapeutic use
Drug Therapy, Combination
Endoscopy, Digestive System / methods
Female
Humans
Liver / diagnostic imaging
Liver / pathology
Liver Neoplasms / diagnostic imaging
Liver Neoplasms / pathology
Liver Neoplasms / secondary
Magnetic Resonance Imaging / methods
Melanoma / genetics
Melanoma / pathology*
Mutation / genetics
Neoplasm Metastasis / pathology
Paclitaxel / administration & dosage
Paclitaxel / therapeutic use
Prognosis
Stomach / diagnostic imaging*
Stomach / pathology
Stomach / ultrastructure
Tomography, X-Ray Computed / methods
Tubulin Modulators / therapeutic use
Uveal Neoplasms / complications
Uveal Neoplasms / pathology

Substances

AZD 6244
Aniline Compounds
Benzimidazoles
MEK inhibitor I
Tubulin Modulators
Acrylonitrile
Paclitaxel